What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences



: Rebelos Eleni, Anastasiou Ioanna A., Tentolouris Anastasios, Papanas Nikolaos, Jude Edward

Publisher: Sage

: 2024

: International Journal of Lower Extremity Wounds

: INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS

: INT J LOW EXTR WOUND

: 5

: 1534-7346

: 1552-6941

DOI: https://doi.org/10.1177/15347346241233938

: https://journals.sagepub.com/doi/10.1177/15347346241233938


Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.



Last updated on 2024-26-11 at 16:06